ghk-cu peptide hair growth studies Guide: Protocols & Results for Canadians ghk-cu hair regrowth studies GHK-CU

This figure is directly comparable to the performance of tirzepatide (Mounjaro) in the SURMOUNT-1 trial, which showed approximately 20.9% weight loss at 72 weeks, and exceeds the approximately 14.9% achieved by semaglutide alone in STEP 1

PMID: 2859636

Chronic GI conditions often require 4-12 weeks of consistent oral use

BPC-157 ARG is studied in preclinical and in vitro models for its effects on collagen synthesis and extracellular matrix dynamics

Candidates typically fall into one of two groups: patients already running a broader anti-aging protocol who want to add a sleep and cellular renewal layer, or patients whose primary complaint is poor sleep quality and who want a protocol that addresses the underlying circadian biology rather than just supplementing melatonin